Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy.

Science translational medicine·2023
Same author

Utilizing PET and MALDI Imaging for Discovery of a Targeted Probe for Brain Endocannabinoid <i>α</i>/<i>β</i>-Hydrolase Domain 6 (ABHD6).

Journal of medicinal chemistry·2022
Same author

Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine.

International journal of molecular sciences·2021
Same author

Evaluation of FASN inhibitors by a versatile toolkit reveals differences in pharmacology between human and rodent FASN preparations and in antiproliferative efficacy in vitro vs. in situ in human cancer cells.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2020
Same author

High-Resolution Confocal Fluorescence Imaging of Serine Hydrolase Activity in Cryosections - Application to Glioma Brain Unveils Activity Hotspots Originating from Tumor-Associated Neutrophils.

Biological procedures online·2020
Same author

Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications.

Drug discovery today·2019

Related Experiment Video

Updated: Mar 20, 2026

A Step Beyond BRET: Fluorescence by Unbound Excitation from Luminescence FUEL
07:04

A Step Beyond BRET: Fluorescence by Unbound Excitation from Luminescence FUEL

Published on: May 23, 2014

12.1K

A Sensitive and Versatile Fluorescent Activity Assay for ABHD12.

Juha R Savinainen1, Dina Navia-Paldanius1, Jarmo T Laitinen2

  • 1School of Medicine, Institute of Biomedicine/Physiology, University of Eastern Finland, Kuopio, Finland.

Methods in Molecular Biology (Clifton, N.J.)
|June 2, 2016
PubMed
Summary

Researchers developed a new assay to measure the activity of the α/β-hydrolase domain containing 12 (ABHD12) enzyme. This assay enables the discovery of selective ABHD12 inhibitors, crucial for understanding metabolic serine hydrolase functions.

Keywords:
2-AG hydrolaseEndocannabinoidFluorescenceGlycerolInhibitorLipaseMonoacylglycerolNatural substrateScreening

More Related Videos

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.4K
High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay
08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

9.7K

Related Experiment Videos

Last Updated: Mar 20, 2026

A Step Beyond BRET: Fluorescence by Unbound Excitation from Luminescence FUEL
07:04

A Step Beyond BRET: Fluorescence by Unbound Excitation from Luminescence FUEL

Published on: May 23, 2014

12.1K
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.4K
High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay
08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

9.7K

Area of Science:

  • Biochemistry
  • Enzymology
  • Molecular Biology

Background:

  • The human metabolic serine hydrolase (mSH) family comprises numerous enzymes with unclear fundamental roles.
  • α/β-hydrolase domain containing 12 (ABHD12) is an mSH enzyme with lysophosphatidylserine (LPS) as its apparent in vivo substrate.
  • ABHD12, along with MAGL and ABHD6, also hydrolyzes monoacylglycerols (MAGs) like 2-arachidonoyl glycerol (2-AG) in vitro.

Purpose of the Study:

  • To develop a sensitive, high-throughput fluorescent assay for measuring ABHD12 enzyme activity.
  • To establish a method for screening inhibitors selective for ABHD12 over other mSH enzymes.
  • To facilitate the study of ABHD12 function and the identification of novel therapeutic modulators.

Main Methods:

  • A 96-well-plate fluorescent assay was developed using lysates from HEK293 cells overexpressing human ABHD12.
  • The assay monitors glycerol liberation from the hydrolysis of 1(3)-acylglycerol (1(3)-AG), the preferred MAG substrate for ABHD12.
  • Glycerol detection is coupled to an enzymatic cascade producing the fluorescent product resorufin, enabling kinetic monitoring.

Main Results:

  • The developed assay allows for the simultaneous testing of inhibitor activities for up to 40 compounds.
  • This methodology successfully identified the first class of inhibitors exhibiting selectivity for ABHD12 compared to other mSHs.
  • The assay provides a sensitive and efficient means to study ABHD12 enzyme kinetics and inhibition.

Conclusions:

  • A novel, sensitive fluorescent assay for ABHD12 activity has been established, suitable for high-throughput screening.
  • This assay facilitates the discovery of selective ABHD12 inhibitors, advancing research into mSH enzyme functions.
  • The findings pave the way for further investigation into the physiological roles of ABHD12 and the development of targeted therapeutics.